Similar articles for PMID: 19523302

Year	Number of Results
1976	1
1992	1
1995	3
1998	1
1999	2
2000	3
2001	3
2002	4
2003	1
2005	5
2006	4
2007	11
2008	8
2009	19
2010	13
2011	7
2012	2
2013	7
2014	4
2015	2
2016	3
2017	3
2018	4
2019	1
2020	2
2021	1
2022	2
2024	0

1

Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.

Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV. Xynos ID, et al. Emerg Infect Dis. 2009 Jun;15(6):956-9. doi: 10.3201/eid1506.090101. Emerg Infect Dis. 2009. PMID: 19523302 Free PMC article. Review.

2

Expanding possibilities in the treatment of patient groups with previously difficult-to-treat patients.

Dörner T, Burmester GR. Dörner T, et al. Curr Opin Rheumatol. 2010 May;22(3):235-6. doi: 10.1097/BOR.0b013e3283385559. Curr Opin Rheumatol. 2010. PMID: 20351494 No abstract available.

3

B cell depletion in autoimmune rheumatic diseases.

Pitashny M, Shoenfeld Y. Pitashny M, et al. Autoimmun Rev. 2005 Sep;4(7):436-41. doi: 10.1016/j.autrev.2005.03.002. Epub 2005 Apr 1. Autoimmun Rev. 2005. PMID: 16137609 Review.

4

mAbs in nonlupus autoimmune rheumatic disease.

Whelan BR, Isenberg DA. Whelan BR, et al. Curr Opin Hematol. 2009 Jul;16(4):280-4. doi: 10.1097/MOH.0b013e32832c1f53. Curr Opin Hematol. 2009. PMID: 19444098 Review.

5

Biologic treatment of pediatric rheumatic diseases: are we spoilt for choice?

van Royen-Kerkhof A, Vastert BS, Swart JF, Wulffraat NM. van Royen-Kerkhof A, et al. Immunotherapy. 2014;6(1):1-3. doi: 10.2217/imt.13.153. Immunotherapy. 2014. PMID: 24341875 Free article. No abstract available.

6

Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.

Franklin G, Greenspan J, Chen S. Franklin G, et al. Ann Clin Lab Sci. 2009 Spring;39(2):192-5. Ann Clin Lab Sci. 2009. PMID: 19429808

7

Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy--a research agenda for Europe.

Zanger P, Gabrysch S. Zanger P, et al. Euro Surveill. 2013 Jul 25;18(30):20542. doi: 10.2807/1560-7917.es2013.18.30.20542. Euro Surveill. 2013. PMID: 23929182 Free article.

8

Biologics in the treatment of skin and rheumatologic diseases.

Kahlenberg JM, Billi AC, Eyerich K, Gudjonsson JE. Kahlenberg JM, et al. J Allergy Clin Immunol. 2020 Apr;145(4):1138-1141. doi: 10.1016/j.jaci.2020.02.017. Epub 2020 Feb 27. J Allergy Clin Immunol. 2020. PMID: 32112793 Free PMC article. Review. No abstract available.

9

Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages.

Arens K, Filippis C, Kleinfelder H, Goetzee A, Reichmann G, Crauwels P, Waibler Z, Bagola K, van Zandbergen G. Arens K, et al. Front Immunol. 2018 Jul 31;9:1772. doi: 10.3389/fimmu.2018.01772. eCollection 2018. Front Immunol. 2018. PMID: 30108591 Free PMC article.

10

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.

Kalden JR. Kalden JR. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S34-40. doi: 10.1186/ar552. Epub 2002 May 24. Arthritis Res. 2002. PMID: 12110156 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year